FDA Inspection 600197 — Allergan Pharmaceuticals Ireland

Allergan Pharmaceuticals Ireland — FEI 3002806285

The FDA completed an inspection of Allergan Pharmaceuticals Ireland on July 10, 2009 in Westport. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 10, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Westport (Ireland)